16 New GLP-1 Weight-loss Drugs Could Be Launched by 2029: Report
Looking Into Applied DNA Sciences's Recent Short Interest
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
Tonix Pharmaceuticals Soars After Positive Data on Its Potential Mpox Vaccine